Follicular lymphoma (FL) accounts for 10–15% of non-Hodgkin’s lymphomas in western countries. Although patients with FL experience a relatively indolent course and usually exhibit dramatic responses to initial therapy, they should be considered affected by a fatal malignancy. There is a tendency to relapse over time, the response to salvage treatments is of shorter duration after every relapse, and patients eventually die of disease-related causes. Several treatment approaches are offered to patients with FL; however, criteria to rationalize treatment decisions are still lacking in many instances
Follicular lymphoma is the second most frequent non-Hodgkin lymphoma accounting for about 10-20% of ...
Background: Follicular lymphoma (FL) is second most common lymphoma in adult, constituted 20% of all...
Copyright © 2012 Luca Arcaini et al. This is an open access article distributed under the Creative C...
Follicular lymphoma (FL) accounts for 10\u201315% of non-Hodgkin\u2019s lymphomas in western countri...
Follicular lymphoma (FL) is as an indolent neoplasia with median survival measured in decades. Never...
Although follicular lymphoma (FL) patients relapsing within 24 months after first-line treatment (PO...
Follicular lymphoma (FL) is an indolent lymphoma with long median survival. Many studies have been p...
Despite significant improvements in treatment modalities over the 10 years, the clinical course of p...
Multiple clinical features at diagnosis have been identified as having important prognostic signific...
The prognosis of follicular lymphomas (FL) is heterogeneous and numerous treatments may be proposed....
Purpose The aim of the F2 study was to verify whether a prospective collection of data would ena...
PURPOSE: The aim of the F2 study was to verify whether a prospective collection of data would enable...
Follicular lymphoma (FL) is a heterogeneous disease with varying prognosis owing to differences in c...
Over the last 15 years, the outcome of patients with follicular lymphoma (FL) has dramatically impro...
Introduction: So far prognostic models developed for follicular lymphoma (FL) have been based on re...
Follicular lymphoma is the second most frequent non-Hodgkin lymphoma accounting for about 10-20% of ...
Background: Follicular lymphoma (FL) is second most common lymphoma in adult, constituted 20% of all...
Copyright © 2012 Luca Arcaini et al. This is an open access article distributed under the Creative C...
Follicular lymphoma (FL) accounts for 10\u201315% of non-Hodgkin\u2019s lymphomas in western countri...
Follicular lymphoma (FL) is as an indolent neoplasia with median survival measured in decades. Never...
Although follicular lymphoma (FL) patients relapsing within 24 months after first-line treatment (PO...
Follicular lymphoma (FL) is an indolent lymphoma with long median survival. Many studies have been p...
Despite significant improvements in treatment modalities over the 10 years, the clinical course of p...
Multiple clinical features at diagnosis have been identified as having important prognostic signific...
The prognosis of follicular lymphomas (FL) is heterogeneous and numerous treatments may be proposed....
Purpose The aim of the F2 study was to verify whether a prospective collection of data would ena...
PURPOSE: The aim of the F2 study was to verify whether a prospective collection of data would enable...
Follicular lymphoma (FL) is a heterogeneous disease with varying prognosis owing to differences in c...
Over the last 15 years, the outcome of patients with follicular lymphoma (FL) has dramatically impro...
Introduction: So far prognostic models developed for follicular lymphoma (FL) have been based on re...
Follicular lymphoma is the second most frequent non-Hodgkin lymphoma accounting for about 10-20% of ...
Background: Follicular lymphoma (FL) is second most common lymphoma in adult, constituted 20% of all...
Copyright © 2012 Luca Arcaini et al. This is an open access article distributed under the Creative C...